Compare CCC & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCC | PLSE |
|---|---|---|
| Founded | 1980 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.6B |
| IPO Year | 2020 | 2015 |
| Metric | CCC | PLSE |
|---|---|---|
| Price | $7.66 | $45.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $7.75 | ★ $67.67 |
| AVG Volume (30 Days) | ★ 17.8M | 365.7K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $1,057,001,000.00 | N/A |
| Revenue This Year | $10.10 | $406.29 |
| Revenue Next Year | $8.75 | $157.24 |
| P/E Ratio | $70.05 | ★ N/A |
| Revenue Growth | ★ 11.88 | N/A |
| 52 Week Low | $4.08 | $12.95 |
| 52 Week High | $8.68 | $58.94 |
| Indicator | CCC | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 58.86 | 39.93 |
| Support Level | $5.72 | $43.32 |
| Resistance Level | $7.68 | $57.14 |
| Average True Range (ATR) | 0.02 | 4.43 |
| MACD | -0.03 | -1.23 |
| Stochastic Oscillator | 21.43 | 13.61 |
CCC Intelligent Solutions Holdings Inc is a provider of cloud, mobile, AI, telematics, hyperscale technologies, and applications for the property and casualty insurance economy. The company's SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, AI-enabled digital workflows. It operates in a single segment being Domestic segment, which provides SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The company has its presence in the United States and China. The majority of the revenue is generated from the United States.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.